Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,912,950
-
Share change
-
-451,180
-
Total reported value
-
$753,705
-
Price per share
-
$0.39
-
Number of holders
-
19
-
Value change
-
-$200,699
-
Number of buys
-
7
-
Number of sells
-
12
Institutional Holders of Sensei Biotherapeutics, Inc. - COM (SNSE) as of Q1 2025
As of 31 Mar 2025,
Sensei Biotherapeutics, Inc. - COM (SNSE) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,912,950 shares.
The largest 10 holders included
VANGUARD GROUP INC, Ikarian Capital, LLC, Catalio Capital Management, LP, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, UBS Group AG, NORTHERN TRUST CORP, STATE STREET CORP, and Cresset Asset Management, LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.